市场调查报告书
商品编码
1465120
电穿孔设备市场:按应用、最终用户划分 - 2024-2030 年全球预测Electroporation Instrument Market by Application (Biomedical Research, Protein Production), End-user (Academic & Research Institutions, Pharmaceutical & Biotechnology Companies) - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年电穿孔设备市场规模为2.6706亿美元,预计2024年将达2.810亿美元,2030年将达3.8844亿美元,复合年增长率为5.49%。
电穿孔设备是专为电穿孔过程设计的先进设备,电穿孔是一种用于增加细胞膜渗透性的微生物技术。该过程透过向细胞施加电场,将 DNA、RNA、蛋白质和化学物质等物质引入细胞中。对合成基因不断增长的需求,以及对个人化医疗日益增长的兴趣,正在加速市场创新。然而,与先进电穿孔技术相关的高成本以及精确控制电参数以避免细胞损伤的需求正在阻碍市场成长。此外,在製药和生物技术公司大量投资的支持下,电穿孔技术的进步正在为市场成长创造利润丰厚的机会。
主要市场统计 | |
---|---|
基准年[2023] | 26706万美元 |
预测年份 [2024] | 2.81 亿美元 |
预测年份 [2030] | 38844万美元 |
复合年增长率(%) | 5.49% |
应用慢性病的增加推动电穿孔设备在生物医学研究的应用
在生物医学研究领域,电穿孔对于将外源核酸引入细胞极为重要。这个过程对于基因治疗、癌症研究和各种遗传疾病的研究至关重要。电穿孔后的精确度、效率和细胞活力是关键因素。专注于生物医学研究的实验室优先考虑提供高通量能力、可自订的电穿孔参数和最低细胞杀伤率的设备,以确保实验结果的可靠性和可重复性。电穿孔已成为蛋白质生产领域的重要工具,特别是在重组蛋白质疗法的开发中。 DNA 引入宿主细胞的效率对所产生的蛋白质的产量和品质有直接影响。
最终用户製药和生物技术公司更喜欢更准确和扩充性的电穿孔设备。
学术和研究机构的一个关键需求是经济实惠、易于使用且多功能的电穿孔系统,该系统可以支援广泛的研究应用,例如基因功能研究、治疗开发和疫苗研究。为了支持大批量遗传研究和 CRISPR 基因编辑计划,对能够同时处理多个样本的高通量系统的需求不断增长。製药和生物技术公司包括从事药物发现、治疗开发和生物技术研究的公司。这些公司优先考虑提供精确性、扩充性以及与药物筛检和治疗开发现有工作流程整合的能力的电穿孔仪器。高效转染困难细胞类型(包括原代细胞和干细胞)是确保新型治疗方法(包括基于基因编辑和细胞疗法的疗法)成功的关键要求。
区域洞察
包括美国和加拿大在内的美洲地区专注于生物技术和製药领域的研发,推动了对电穿孔设备的需求。该市场的特点是对最尖端科技的高投资,并出现了许多创新的电穿孔技术和设备改进。该地区的消费者重视电穿孔设备的可靠性、效率和先进功能。欧盟 (EU) 市场的特点是严格的监管标准以及对研究诚信和道德考虑的重视。欧盟国家对电穿孔设备的需求是由先进的医疗保健系统、强大的研究环境以及大量的政府和私人资金所推动的。中国、日本和印度是亚太地区的关键地区,政府对生物技术研究投入大量资金,製药业蓬勃发展,与国际生物技术公司的合作日益增多,推动了电穿孔设备市场的快速扩张。日本市场高度发达,强调创新和品质。
FPNV定位矩阵
FPNV定位矩阵对于评估电穿孔设备市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对电穿孔设备市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.电穿孔设备市场的市场规模与预测为何?
2.在电穿孔设备市场的预测期间内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.电穿孔设备市场的技术趋势与法规结构是什么?
4.电穿孔设备市场主要供应商的市场占有率为何?
5.进入电穿孔设备市场合适的型态和策略手段是什么?
[184 Pages Report] The Electroporation Instrument Market size was estimated at USD 267.06 million in 2023 and expected to reach USD 281.00 million in 2024, at a CAGR 5.49% to reach USD 388.44 million by 2030.
An electroporation instrument is a sophisticated device designed for the process of electroporation, which is a microbiological technique used to increase the permeability of cell membranes. This process allows for the introduction of substances such as DNA, RNA, proteins, & chemicals into the cell by using an electrical field to the cells, creating temporary pores in the membrane through which materials can be introduced. Rising demand for synthetic genes, along with the growing emphasis on personalized medicine, is accelerating innovation in the market. However, high costs associated with sophisticated electroporation technologies and the requirement for precise control over electrical parameters to avoid cell damage impede market growth. Furthermore, advancements in electroporation techniques supported by significant investments from pharmaceutical & biotechnology companies create lucrative opportunities for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 267.06 million |
Estimated Year [2024] | USD 281.00 million |
Forecast Year [2030] | USD 388.44 million |
CAGR (%) | 5.49% |
Application: Growing prevalence of chronic disorder boost the utilization of electroporation iInstrument in biomedical research
In the realm of biomedical research, electroporation instruments are pivotal for introducing foreign nucleic acids into cells. This process is vital for gene therapy, cancer research, and the study of various genetic disorders. The precision, efficiency, and cell viability rates post-electroporation are crucial factors considered. Laboratories focused on biomedical research prioritize instruments offering high-throughput capabilities, customizable electroporation parameters, and minimal cell mortality to ensure the reliability and reproducibility of experimental results. Electroporation has become an indispensable tool in the field of protein production, particularly in the development of recombinant protein therapeutics. The efficiency of DNA introduction into host cells instantly affects the yield and quality of the produced proteins.
End-user: Pharmaceutical & biotechnology companies prefer electroporation instrument with more precision & scalability
Academic & research institutions' primary needs revolve around affordable, user-friendly, and versatile electroporation systems that can support a wide range of research applications such as gene function studies, therapeutic development, and vaccine research. High-throughput systems that can process multiple samples simultaneously are increasingly in demand to support high-volume genetic research and CRISPR gene-editing projects. Pharmaceutical & biotechnology companies cover companies involved in drug discovery, therapeutic development, and biotechnological research. They prioritize electroporation instruments that offer precision, scalability, and integration capabilities with existing workflows for drug screening and therapeutic development. Efficiency in transfecting challenging cell types, including primary cells and stem cells, is a crucial demand to ensure the success of novel therapies, including those based on gene editing and cell therapy.
Regional Insights
In the American region encompassing the United States and Canada, a significant emphasis on research and development in the biotechnological and pharmaceutical sectors drives demand for electroporation instruments. The market is characterized by high investment in cutting-edge technology, with numerous innovative electroporation techniques and apparatus improvements. Consumers in the region value reliability, efficiency, and advanced features in electroporation instruments. The European Union market is distinguished by stringent regulatory standards and a strong focus on research integrity and ethical considerations. Demand for electroporation instruments in EU countries is driven by advanced healthcare systems, robust research environments, and substantial government and private funding. China, Japan, & India are the major regions in the Asia Pacific region, with their market for electroporation instruments expanding rapidly due to substantial government investment in biotechnology research, a burgeoning pharmaceutical industry, and increasing collaboration with international biotech firms. Japan's market is highly developed, with a strong emphasis on innovation and quality.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Electroporation Instrument Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Electroporation Instrument Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Electroporation Instrument Market, highlighting leading vendors and their innovative profiles. These include ALA Scientific Instruments, Inc., Bertin Technologies SAS, Bio-Rad Laboratories, Inc., BTX by Harvard Bioscience, Inc., Celetrix, LLC, Eppendorf SE, Inovio Pharmaceuticals Inc., Lonza Group Ltd., MaxCyte, Inc., Mirus Bio LLC, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Electroporation Instrument Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Electroporation Instrument Market?
3. What are the technology trends and regulatory frameworks in the Electroporation Instrument Market?
4. What is the market share of the leading vendors in the Electroporation Instrument Market?
5. Which modes and strategic moves are suitable for entering the Electroporation Instrument Market?